Shin Nippon Biomedical Lab.Ltd Registered Shares o.N.
- BID
6.9
- ASK
7.05
- 290 Units284 Units
- 07/21, 19:03:57 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
11.61%
Market Cap
-
P/E Ratio
12.89
Dividend Yield
3.54 %
Earnings per Share
0.63 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 6.9 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 07:02:07 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 7 | 6.9 |
| PREV. DAY'S PRICE | 6.85 | (07/20) |
| CHANGE DAY BEFORE | +0.05 | 0.73 % |
| 52 WEEK HIGH / LOW | 10.6 (12/11) | 5.7 (06/09) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.85 | 0.72 | 0.63 | 0.51 | 0.52 |
DIVIDENDS PER SHARE | 0.32 | 0.31 | 0.29 | 0.27 | 0.27 |
DIVIDEND YIELD IN % | 3.29 % | 3.49 % | 3.54 % | - | - |
DIVIDEND GROWTH IN % | -10.18 % | -4.28 % | -6.30 % | - | - |
PRICE - EARNINGS RATIO | 11.43 | 12.10 | 12.89 | 13.48 | 13.29 |
PRICE - BOOK RATIO | 1.85 | 1.49 | 1.37 | - | - |
PRICE - SALES RATIO | 2.39 | 1.84 | 1.81 | - | - |
PRICE - CASH FLOW RATIO | 30.00 | 8.47 | 7.07 | - | - |
Master Data
| WKN | A0BMJN |
| ISIN | JP3379950003 |
| SYMBOL | YB3 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Shin Nippon Biomedical Laboratories |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.84 % | 18.10 % | -13.84 % | -20.35 % | -11.61 % | -46.06 % | -13.84 % | -23.89 % |
| HIGH | 7.10 | 7.10 | 8.05 | 9.60 | 10.60 | 15.30 | 21.60 | 9.60 |
| LOW | 6.80 | 5.80 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
Dividende
pro Aktie
Company profile
Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. Its operations are carried out through the following segments: CRO Business, Translational Research Business, Medipolis Business, and Others. he CRO business is a business that verifies the efficacy and safety of test substances created by clients such as pharmaceutical companies using laboratory animals, cells, and bacteria. The Translational Research Business segment utilizes drug and device development capabilities to accelerate drug development which leads to out-licensing to pharmaceutical companies. The Medipolis Business segment deals with the property management and geothermal power generation businesses. The Others segment engages in the information collection in Europe, which includes real estate and environmental equipment operations. The company was founded in April 1957 and is headquartered in Tokyo, Japan.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.